You can buy or sell Catalent and other stocks, options, ETFs, and crypto commission-free!
CATALENT, INC., also called Catalent, is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. Read More The Softgel Technologies segment focuses on the formulation, development, and manufacture of prescription and consumer health soft capsules, softgels, vegicaps and optishell capsules. The Biologics and Specialty Drug Delivery segment researches and develop biologic drug products in prefilled syringes, vials, cartridges, blow-fill-seal unit doses, and injectable formats. The Oral Drug Delivery segment offers formulates oral dosage forms. The Clinical Supply Services segment includes the packaging, labeling, storage, distribution, and inventory management of patient kits for clinical trials of drugs. It also provides clinical e-solutions and informatics, and global comparator sourcing services. The company was founded in April 2007 and is headquartered in Somerset, NJ.
Somerset, New Jersey
52 Week High
52 Week Low
Recent Fundamentals: Catalent (NYSE: CTLT)
Catalent trades as part of the drug manufacturers industry and trades as part of the healthcare sector. The company CEO is John R. Chiminski. Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets. Previous Intraday Trading Performance: The CTLT stock showed a previous change of 0.24% with an open at 42.69 and a close ...
Stock Price, News, & Analysis for Catalent
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary su...
Yahoo FinanceMar 15
CTLT or NBIX: Which Is the Better Value Stock Right Now?
CTLT vs. NBIX: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalent (CTLT) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores syst...
Expected Apr 30, Pre-Market